Literature DB >> 19368660

Absence of the interstitial cell of Cajal network in mitochondrial neurogastrointestinal encephalomyopathy.

V Zimmer1, W Feiden, G Becker, A Zimmer, W Reith, J Raedle, F Lammert, S Zeuzem, M Hirano, M Menges.   

Abstract

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is a rare autosomal-recessive multisystemic disorder with predominant gastrointestinal involvement, presenting with variable degrees of gut dysmotility up to frank chronic intestinal pseudoobstruction. Despite major advances in understanding its basic molecular pathogenesis in recent years, the distinct mechanisms and pathoanatomical substrate underlying MNGIE-associated gastrointestinal dysmotility are still widely unknown. As yet, though their critical role in proper gastrointestinal transit in terms of spontaneous pacemaker activity and enteric neurotransmission is well established, the population of the interstitial cells of Cajal (ICC) has not been investigated in MNGIE. Therefore, we examined small bowel samples of a well-characterized MNGIE patient by using conventional histology and immunohistochemistry techniques. The ICC network was studied by immunohistochemistry for the tyrosine kinase Kit (CD117), known to reliably detect ICCs, while mucosal mast cells served as an internal and normal small bowel specimen as external controls. At a light microscopic level, no gross structural alteration of the bowel wall composition and its neuromuscular elements was noted. However, a complete absence of Kit immunoreactive cells could be demonstrated in regions where ICCs are normally abundant, while internal and external controls retained strong Kit positivity. In conclusion, our preliminary results provide a first evidence for an alteration of the ICC network in MNGIE, and support the notion that ICC loss might be an early pathogenetic event in MNGIE-associated gut motor dysfunction before significant myopathic and/or neuropathic structural changes occur.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19368660     DOI: 10.1111/j.1365-2982.2009.01264.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  9 in total

1.  Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy.

Authors:  Caterina Garone; Saba Tadesse; Michio Hirano
Journal:  Brain       Date:  2011-09-20       Impact factor: 13.501

2.  Diagnosis of mitochondrial neurogastrointestinal encephalomyopathy: proposal of a clinical algorithm.

Authors:  Vincent Zimmer; Michio Hirano; Anna Zimmer; Frank Lammert
Journal:  Dig Liver Dis       Date:  2014-04-13       Impact factor: 4.088

Review 3.  Mitochondrial Neurogastrointestinal Encephalomyopathy Caused by Thymidine Phosphorylase Enzyme Deficiency: From Pathogenesis to Emerging Therapeutic Options.

Authors:  Rana Yadak; Peter Sillevis Smitt; Marike W van Gisbergen; Niek P van Til; Irenaeus F M de Coo
Journal:  Front Cell Neurosci       Date:  2017-02-15       Impact factor: 5.505

Review 4.  Peripheral neuropathy and gastroenterologic disorders: an overview on an underrecognized association.

Authors:  Carlotta Spagnoli; Francesco Pisani; Francesco Di Mario; Gioacchino Leandro; Federica Gaiani; Gian Luigi De' Angelis; Carlo Fusco
Journal:  Acta Biomed       Date:  2018-12-17

Review 5.  Mitochondrial Neurogastrointestinal Encephalomyopathy: Into the Fourth Decade, What We Have Learned So Far.

Authors:  Dario Pacitti; Michelle Levene; Caterina Garone; Niranjanan Nirmalananthan; Bridget E Bax
Journal:  Front Genet       Date:  2018-12-21       Impact factor: 4.599

Review 6.  Gastrointestinal Dysmotility in MNGIE: from thymidine phosphorylase enzyme deficiency to altered interstitial cells of Cajal.

Authors:  Rana Yadak; Marjolein Breur; Marianna Bugiani
Journal:  Orphanet J Rare Dis       Date:  2019-02-08       Impact factor: 4.123

7.  Circulating miRNAs as Biomarkers for Mitochondrial Neuro-Gastrointestinal Encephalomyopathy.

Authors:  Mark Mencias; Michelle Levene; Kevin Blighe; Bridget E Bax
Journal:  Int J Mol Sci       Date:  2021-04-01       Impact factor: 5.923

Review 8.  Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE-MTDPS1).

Authors:  Massimiliano Filosto; Stefano Cotti Piccinelli; Filomena Caria; Serena Gallo Cassarino; Enrico Baldelli; Anna Galvagni; Irene Volonghi; Mauro Scarpelli; Alessandro Padovani
Journal:  J Clin Med       Date:  2018-10-26       Impact factor: 4.241

9.  Transplantation, gene therapy and intestinal pathology in MNGIE patients and mice.

Authors:  Rana Yadak; Max V Boot; Niek P van Til; Dominique Cazals-Hatem; Armin Finkenstedt; Elly Bogaerts; Irenaeus F de Coo; Marianna Bugiani
Journal:  BMC Gastroenterol       Date:  2018-10-19       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.